Hologic, Inc. (HOLX) Tops Q3 EPS by 1c; Guides Q4, FY12 Revs
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Income from operations: 147M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Income from operations: 147M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q3 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $467 million versus the consensus estimate of $457.43 million.
Hologic, Inc. sees Q4 2011 revs of $465-$470 million, versus the consensus of $467.5 million
Sees FY2012 revenue of $1.9-$1.93 billion, versus the consensus of $1.91 billion.
Hologic, Inc. sees Q4 2011 revs of $465-$470 million, versus the consensus of $467.5 million
Sees FY2012 revenue of $1.9-$1.93 billion, versus the consensus of $1.91 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
